Selank where to buy is a search that tends to happen late in a hard block, when sleep has thinned, appetite has gone strange, and the training is running on adherence rather than enthusiasm. That is the worst possible state to assess a supplier from, because the checks that matter are dull and the marketing is not.
Key takeaways
- Selank is a synthetic heptapeptide, seven residues, Thr-Lys-Pro-Arg-Pro-Gly-Pro, built as an analogue of the immune peptide tuftsin. PubChem CID 11765600, formula C33H57N11O9, molecular weight 751.9.
- It holds no FDA approval for anything. It was nominated as a bulk substance for compounding and the nomination was withdrawn, so it sits on no current 503A category list.
- FDA's stated concern is immunogenicity from aggregation and peptide-related impurities. That converts directly into a purchase criterion: identity, purity and, for anything injected, endotoxin testing.
- Testing scope on the vial we point to changed between batches. The February certificate covers identity, purity and quantity only. The June certificate adds endotoxin, sterility and heavy metals. Check the lot, not the brand.
- A Russian anxiolytic registration is not evidence by Western regulatory standards, and a good supplier does not make Selank work. It only decides what is in the container.
The listing we score against these criteria further down is this one, so it is worth putting the numbers on the table first rather than saving them for a reveal.
The vendor we point lifters to
Selank from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
Selank where to buy: the criteria, stated before any vendor
This is not a vendor list. Vendor lists rot within a quarter, and the ones that do not rot were written to be sold. What survives is the set of things a buyer can verify from outside the business, in the order they actually decide the purchase.
| Criterion | What earns a pass | What a repackager does instead |
|---|---|---|
| Batch-specific certificate | A lot number on the report that matches the vial you are shipped | One undated PDF reused across every batch, or a certificate on request only |
| Purity by HPLC | A numeric percentage with the chromatogram and the peak list behind it | A bare "99%+" in body text with nothing to inspect |
| Identity by mass spectrometry | A measured mass compared against the expected 751.43 Da for Selank | Silence, or a molecular weight copied from a database |
| Endotoxin testing | A quantitative bacterial endotoxins result with a stated limit | Nothing, on the grounds that it is research material |
| Domestic stock | Dispatch from a US facility with tracking that starts domestically | "Ships worldwide" and a three-week window |
| Recourse | A named business, a phone number, a stated returns position | An email form and a Telegram handle |
| Listing compliance | Research-use language, no protocols, no benefit claims | Suggested amounts, before and after images, health claims |
The identity row is the one most buyers skip and the one that separates a supplier from a reseller most cleanly. Purity says the container holds one thing in high proportion. Identity says that one thing is Selank. A certificate answering only the first has answered the easier question. The same framework on a compound with a different risk profile is in our scoring for BPC-157 suppliers.
What you are actually buying, in seven residues
Selank is a synthetic heptapeptide: Thr-Lys-Pro-Arg-Pro-Gly-Pro. The first four residues are tuftsin, a short immune-active peptide the body already makes, and the Pro-Gly-Pro tail is bolted on to slow enzymatic breakdown so the molecule survives long enough to be interesting. It was developed at the Institute of Molecular Genetics in Russia and registered there as an anxiolytic.
The reference figures a certificate should agree with are public. PubChem CID 11765600 gives the formula as C33H57N11O9 and the molecular weight as 751.9. A report claiming a materially different mass is describing a different molecule, and that is a check anyone can run from a phone in under a minute.
Two things it is not: a pentadecapeptide, or a mitochondrial fragment. A product page describing Selank in language lifted from BPC-157 or MOTS-c was assembled rather than written, which tells you something about the rest of it.
The regulatory line, and where competing pages get it wrong
Here is the part almost every "selank peptide where to buy" page gets wrong, usually by repeating something that was true once.
Selank holds no FDA approval for any indication. It also does not sit on the 503A bulks list in any category. FDA's bulk drug substances page for section 503A, content current as of 05/14/2026, does not name it at all.
What did happen is more specific. Selank was nominated as a bulk substance for compounding, was placed in category 2 under the interim policies while FDA evaluated it, and then the nomination was withdrawn by the nominator. It now appears on FDA's safety risks page, content current as of 04/22/2026, under the heading "Bulk drug substances nominated but withdrawn", listed as "Selank acetate (TP-7)".
So the accurate sentence is: nominated, evaluated, withdrawn, currently on no list. Not "FDA Category 2", a status it no longer holds, and not "banned from compounding", which it never was. The Russian registration is real, it is also not FDA approval, and nobody should launder one into the other.
Why immunogenicity is a testing question, not a vibes question
FDA's documented concern is worth reading in the agency's own words, from that same safety risks page:
"Compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA lacks important information regarding any safety issues raised by selank acetate administered to humans."
Aggregation and peptide-related impurities are both manufacturing and handling outcomes. They are the reason purity by HPLC and identity by mass spectrometry are not box-ticking, and they are the reason a bacterial endotoxins result matters for anything that would be injected. Endotoxin is bacterial debris rather than a live organism, it survives the organisms that produced it, and it is measured by its own compendial assay rather than inferred from a clean chromatogram.
This is where the whole "read the COA" instruction earns its keep. A certificate showing 99% purity and a matching mass has said nothing about endotoxin, because endotoxin is not what those instruments measure.
Scoring the listing we point to, including the gap
Ascension's Selank 10 mg lists at $47.50 against a $60.00 reference price and drops to $23.75 with PEPTIDEDECK, which is $2.38 per milligram. Dispatch is same day before 2pm CST, free shipping starts at $250, and the page carries research-use language and declines to discuss reconstitution or amounts, which is the correct answer to that question from a research supplier.
On documentation, the honest reading is that the scope changed between batches, and this is the most useful thing on this page.
The certificate for lot 29-01260229, from MZ Biolabs in Tucson and dated 2026-02-13, is two pages. It gives purity at 99.32% by HPLC-UV with the chromatogram and a two-peak list, confirms identity by mass spectrometry with an expected monoisotopic mass of 751.43 Da against 751.47 Da measured, and reports measured quantity at 12.29 mg per vial against a 10 mg label. Searching that document for endotoxin, LAL, pyrogen or sterility returns nothing, because none of those tests are on it.
The certificate for lot 29-05260628, from Kovera Labs and certified 06/02/2026, is four pages and covers more. Purity 99.371%, identity by LC-MS, net content 11.86 mg against the 10 mg label, a bacterial endotoxin result of less than 0.20 EU/mL against a stated limit of 0.5 EU/mL, a rapid sterility screen returning no growth, and an ICP-MS heavy metals panel returning negative for arsenic, cadmium, lead and mercury. One inconsistency inside that report is worth noting rather than glossing: the endotoxin section is headed as a kinetic chromogenic LAL assay while its own methodology table lists the assay type as kinetic turbidimetric at 660 nm. Both are compendial approaches under USP Chapter 85. The labelling should still agree with itself.
The overfill is the detail worth crediting on both. Publishing an assayed quantity above the label at all is unusual, and 12.29 mg and 11.86 mg are lot-specific measurements rather than a promise about the vial you receive.
So the criterion that decides this purchase is not which brand you buy from. It is which lot you are shipped, and whether its certificate covers the thing FDA actually raised. Ask before ordering. A supplier that answers with a lot number is doing the job; one that answers with a testimonial is not.
What a hard block does not excuse
The reason this article opens on tired lifters is that the purchase decision degrades with the same things Selank is marketed against. Sleep debt, an aggressive deficit and accumulated volume without a deload all make a checkout button look like a solution, and none of them make a certificate less worth reading.
They are also the causes with real evidence behind them, and they cost nothing to address first. Our write-up on how poor sleep and cortisol stall progress is the unglamorous version of the same problem, and readers arriving from the fatigue side of the search usually end up comparing this against where to buy NAD+, which sits in the same channel with a different documented failure mode.
One more thing the criteria cannot buy. There is no finished Western efficacy trial establishing what Selank does in healthy trained people, and the registered trial record is the check on any seller implying otherwise. A supplier decides what is in the vial. Nothing beyond that.
Frequently asked questions
What matters most when deciding where to buy Selank?
A batch-specific certificate whose lot number matches the vial you are shipped, with purity by HPLC, identity by mass spectrometry against the expected 751.43 Da, and a bacterial endotoxins result if the material would be injected. Domestic dispatch and a named business with a returns position come next. Price is the last thing to look at, not the first.
Is Selank banned from compounding in the United States?
No, and pages saying so are repeating an outdated status. Selank was nominated as a bulk substance, sat in category 2 under FDA's interim policies during evaluation, and the nomination was then withdrawn by the nominator. It appears on FDA's safety risks page under "Bulk drug substances nominated but withdrawn" and on no current 503A category list. There is also no FDA approval for any indication.
Why does endotoxin testing keep coming up for a peptide?
Because it is the specific concern FDA documented. The agency's language is that compounded drugs containing selank acetate may pose risk for immunogenicity due to the potential for aggregation and peptide-related impurities. Endotoxin is measured by its own assay and is invisible to the HPLC and mass spectrometry results that most certificates stop at, so a clean purity figure does not answer it.
Where does Selank nasal spray fit into this?
The spray is the common consumer format and a lyophilised vial is the common research format, and they are sold by different kinds of business under different rules. The vendor covered here sells the vial, not a spray. The format changes what sterility and endotoxin testing are worth, so the criteria above do not transfer between them unchanged.
Does buying from a better supplier make Selank work?
No. It decides what is in the container and nothing else. There is no finished Western efficacy trial for Selank in healthy trained people, the Russian anxiolytic registration is not FDA approval, and second-hand citations of Russian-language trials are routinely stronger than the trials themselves.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Selank, PubChem CID 11765600
- Certificate of analysis, Selank lot 29-01260229, MZ Biolabs
- Certificate of analysis, Selank lot 29-05260628, Kovera Labs
- Registered studies of Selank, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Selank holds no FDA approval for any indication, material sold by research suppliers is labeled for laboratory use only and not for human consumption, and a foreign registration is not an FDA approval or evidence of efficacy by Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or off-label compounds.